Cu/TI mediates cuproptosis via mitochondrial oxidative stress, DLAT aggregation, and FDX1 downregulation, releasing DAMPs to reverse the low immunogenicity of cancer cells (Li et al., 2024c). The gene discussed is DLAT; the disease is cancer.